Skip to main content
CONTROL BIONICS LIMITED logo

CONTROL BIONICS LIMITED — Investor Relations & Filings

Ticker · CBL ISIN · AU0000114183 ASX Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2026-05-13 Board/Management Inform…
Country AU Australia
Listing ASX CBL

About CONTROL BIONICS LIMITED

https://www.controlbionics.com/

Control Bionics Limited is a medical technology company specializing in advanced assistive communication and control devices. The company develops and commercializes neural interface technology designed to assist individuals with severe physical disabilities, such as Amyotrophic Lateral Sclerosis (ALS), Motor Neurone Disease (MND), and spinal cord injuries. Its flagship product, the NeuroNode, is a non-invasive, wearable sensor that utilizes electromyography (EMG) and spatial data to detect minute muscle signals or neural intent. This technology enables users to control computers, mobile devices, and speech-generating software without the need for physical movement or voice. By integrating neural signaling with eye-tracking and other assistive modalities, the company provides multi-modal solutions that enhance autonomy and communication for patients with limited motor function.

Recent filings

Filing Released Lang Actions
Leading neurotechnology pioneer Prof Nicholas Opie joins CBL 4 pages 248.2KB
Board/Management Information Classification · 92% confidence The document is an ASX announcement detailing the appointment of Professor Nicholas Opie as a Non-Executive Director and strategic advisor, along with the retirement of an existing Non-Executive Director. This is clearly an announcement of changes in the company’s board of directors, fitting the Board/Management Information category.
2026-05-13 English
Final Director's Interest Notice - Phillips 2 pages 310.5KB
Director's Dealing Classification · 94% confidence The document is an ASX Appendix 3Z “Final Director’s Interest Notice” disclosing the director’s relevant interests in securities (personal share holdings and trusts), consistent with an insider transaction report. This aligns with the definition for Director’s Dealing (DIRS).
2026-05-13 English
Initial Director's Interest Notice - Opie 2 pages 351.6KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3X Initial Director’s Interest Notice, which discloses a new director’s relevant interests in securities and contracts under listing rule 3.19A.1. This is a typical insider dealing notification by a director. Therefore, it should be classified as a Director’s Dealing (DIRS).
2026-05-13 English
Proposed issue of securities - CBL 5 pages 18.7KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 3B form detailing a proposed issue of new securities (options) including issue quantity, consideration, timing, and Listing Rule conditions. This is a direct announcement of a share issue/capital change under ASX rules. It does not contain financial statements or broader report content, but specifically relates to issuing new securities. Therefore it fits the "Share Issue/Capital Change" category (Code: SHA).
2026-05-13 English
Control Bionics Strategic Transition Presentation 21 pages 1.5MB
Regulatory Filings
2026-05-04 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 501.8KB
Regulatory Filings
2026-04-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.